Top of this page
Skip navigation, go straight to the content
Our Science
•
Alprostadil (Prostavasin®)
Clinical Study Information - Prostavasin® (alprostadil)
| Disease area studied |
Abbreviated title | Phase | Study ID | Registry database | Study results | Lay summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Intermittent Claudication | Prostaglandin E1 in Outpatients With Intermittent Claudication | Phase 3 |
SP0580 Completed |
NCT01263925 |
LINK |
Schellong SM, et al. Vasa; 2017,46(5):403-405 |
|
| Peripheral Arterial Occlusive Disease | Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (ESPECIAL) | Phase 4 |
SP0777 Completed |
NCT00596752 |
LINK |
Lawall, H. et al. Eur J Vasc Endovasc Surg; 2017, 53(4):559-566 | |
| Macular Degeneration | Alprostadil in Maculopathy Study (AIMS) | Phase 3 |
SP0878 Terminated |
NCT00619229 |
LINK LINK |
Augustin et al. Expert Opin Investig Drugs; 2013;22;7; 803-812. |